Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 24, 2005
has subject area
- 11 Medical and Health Sciences (FoR)
- Adult (MeSH)
- Depression (MeSH)
- Drug Administration Schedule (MeSH)
- Evidence-Based Medicine (MeSH)
- Female (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Infant, Newborn (MeSH)
- Maternal-Fetal Exchange (MeSH)
- Neonatal Abstinence Syndrome (MeSH)
- Pregnancy (MeSH)
- Pregnancy Complications (MeSH)
- Pregnancy Trimester, Third (MeSH)
- Risk Factors (MeSH)
- Selective Serotonin Reuptake Inhibitors (MeSH)